Cellebrite DI (CLBT) Gains from Investment Securities (2020 - 2025)

Cellebrite DI (CLBT) has reported Gains from Investment Securities for 6 consecutive years, with -$2.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Gains from Investment Securities fell 209.18% year-over-year to -$2.0 million; the TTM figure through Dec 2025 stood at $11.4 million (up 161.21% YoY), while the FY2025 annual figure was $11.2 million, up 44.74% from the prior year.
• Gains from Investment Securities came in at -$2.0 million for Q4 2025 at Cellebrite DI, down from $287000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $12.5 million in Q2 2023, with the low at -$15.5 million in Q4 2021.
• Average Gains from Investment Securities over 5 years is $915300.0, with a median of $406000.0 recorded in 2022.
• Across the five-year window, Gains from Investment Securities sank 1970.23% in 2021 and soared 5258.16% in 2025, its largest moves.
• Year by year, Gains from Investment Securities stood at -$15.5 million in 2021, then surged by 99.14% to -$133000.0 in 2022, then sank by 611.28% to -$946000.0 in 2023, then surged by 292.39% to $1.8 million in 2024, then sank by 209.18% to -$2.0 million in 2025.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered -$2.0 million, $287000.0, and $12.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.